Evaluation of Pegfilgrastim Use Following Ambulatory Autologous Hematopoietic Stem Cell Transplant with Melphalan Conditioning

Puntos clave

• Blood cell recovery is improved following pegfilgrastim administration after hematopoietic stem cell transplant.
• Key metric shows faster recovery times in patients receiving pegfilgrastim compared to those who do not.
• Analysis of outcomes from patients undergoing melphalan conditioning reveals beneficial effects of pegfilgrastim.
• Highlights the potential for pegfilgrastim to enhance recovery rates, but further studies are needed to confirm effectiveness.